|

Cromolyn Sodium (17.1 mg BID) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Cromolyn, PHENOGENE-1A, Sodium Cromoglycate

Scottsdale, Arizona1 trial

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Honor Health Neurology - Bob Bove Neuroscience Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.